Companies House true 2024-04-01 2025-03-31 false 14009868 uk-bus:Director1 2024-04-01 2025-03-31 14009868 uk-bus:Director2 2024-04-01 2025-03-31 14009868 2024-04-01 2025-03-31 14009868 2025-03-31 14009868 uk-bus:EntityHasNeverTraded 2024-04-01 2025-03-31 14009868 uk-bus:FRS102 2024-04-01 2025-03-31 14009868 uk-bus:FullAccounts 2024-04-01 2025-03-31 14009868 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 14009868 2024-03-31 14009868 uk-bus:OrdinaryShareClass1 2024-04-01 2025-03-31 14009868 uk-bus:OrdinaryShareClass2 2024-04-01 2025-03-31 14009868 uk-bus:OrdinaryShareClass3 2024-04-01 2025-03-31 14009868 uk-bus:PreferenceShareClass1 2024-04-01 2025-03-31 14009868 uk-bus:PreferenceShareClass2 2024-04-01 2025-03-31 14009868 uk-bus:PreferenceShareClass3 2024-04-01 2025-03-31 14009868 uk-core:ShareCapitalPreferenceShares 2025-03-31 14009868 uk-core:ShareCapitalPreferenceShares 2024-03-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 14009868

EQUINE LIGHT THERAPY LIMITED

Dormant Accounts

31 March 2025

## EQUINE LIGHT THERAPY LIMITED Registered Number 14009868

## Balance Sheet as at 31 March 2025

|  | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Current assets
Cash at bank and in hand |  | 1000 | 1000
Net assets |  | 1000 | 1000
Issued share capital
2 Ordinary Shares of £ 500 each |  | 1000 | 1000
Total Shareholder funds |  | 1000 | 1000

### STATEMENTS

1. For the year ending 31 March 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 March 2025

And signed on their behalf by:
Matthew Bide, Director